FONAR Corporation
$0
▼
-0.1%
2026-07-22 08:04:01
www.fonar.com
NCM: FONR
Explore FONAR Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$139.75 M
Current Price
$0
52W High / Low
$19.16 / $13.9
Stock P/E
20.89
Book Value
$26.21
Dividend Yield
—
ROCE
5.81%
ROE
3.81%
Face Value
—
EPS
$1
Exp Qtr EPS
—
Sector
Healthcare
FONR — Monthly Price History
Adjusted close price · Hover to see price & month
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Thermo Fisher Scientific Inc. | $523.46 | 28.06 | $192.09 B | 0.36% | 8.52% | 13.24% | $643.99 / $403.36 | $141.96 |
| 2. | Danaher Corporation | $179.01 | 34.31 | $126.56 B | 0.78% | 6.12% | 7.06% | $242.8 / $160.93 | $74.32 |
| 3. | IDEXX Laboratories, Inc. | $552.46 | 39.95 | $43.76 B | — | 61.76% | 70.87% | $769.98 / $513.02 | $20.14 |
| 4. | Natera, Inc. | $267.18 | — | $38.06 B | — | -15.84% | -15.13% | $288.04 / $131.81 | $12.26 |
| 5. | Agilent Technologies, Inc. | $132.86 | 26.44 | $37.39 B | 0.77% | 14.25% | 20.84% | $160.27 / $108.35 | $23.82 |
| 6. | Waters Corporation | $367.55 | 79.58 | $35.75 B | — | 20.92% | 8.04% | $414.15 / $275.05 | $43.01 |
| 7. | IQVIA Holdings Inc. | $201.62 | 24.26 | $33.61 B | — | 10.59% | 22.46% | $247.05 / $154.5 | $38.34 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 25.55 M | 26.04 M | 27.28 M | 27.16 M | 24.95 M | — |
| Operating Profit | 3 M | 3.19 M | 0.89 M | 3.66 M | 2.44 M | — |
| Net Profit | 2.06 M | 2.26 M | 0.73 M | 2.51 M | 1.96 M | — |
| EPS in Rs | 0.33 | 0.37 | 0.12 | 0.41 | 0.32 | 0.46 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 104.35 M | 102.88 M | 98.65 M | 97.59 M |
| Operating Profit | 11.6 M | 16.54 M | 14.79 M | 22.01 M |
| Net Profit | 8.33 M | 10.57 M | 9.38 M | 12.44 M |
| EPS in Rs | 1.35 | 1.71 | 1.52 | 2.02 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 216.91 M | 214.25 M | 200.58 M | 199.34 M |
| Total Liabilities | 56.8 M | 57.46 M | 49.75 M | 53.11 M |
| Equity | 172.61 M | 165.97 M | 157.91 M | 150.29 M |
| Current Assets | 144.67 M | 140.32 M | 125.66 M | 118.69 M |
| Current Liabilities | 17.12 M | 17.86 M | 15.62 M | 16.75 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 11.26 M | 14.09 M | 14.47 M | 15.3 M |
| Investing CF | -3.8 M | -0.85 M | -4.34 M | -5.18 M |
| Financing CF | -7.47 M | -8.18 M | -7.57 M | -5.86 M |
| Free CF | 7.45 M | 13.27 M | 10.13 M | 10.67 M |
| Capex | -3.82 M | -0.82 M | -4.34 M | -4.63 M |
5Y Margin & Growth History
Last 5 years of annual financial statement data.
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 1.43% | 4.3% | 1.08% | — |
| Earnings Growth % | -21.13% | 12.71% | -24.64% | — |
| Profit Margin % | 7.99% | 10.27% | 9.5% | 12.75% |
| Operating Margin % | 11.12% | 16.07% | 14.99% | 22.55% |
| Gross Margin % | 41.12% | 43.87% | 46.38% | 48.17% |
| EBITDA Margin % | 17.73% | 23.27% | 24.95% | 32.43% |
Dividend & Split History
Latest dividend payments and stock split events.
Dividend History
No dividend history available.
Stock Splits
No stock split history available.